Eiger Biopharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EIGER BIOPHARMS, and what generic alternatives to EIGER BIOPHARMS drugs are available?
EIGER BIOPHARMS has one approved drug.
There are two US patents protecting EIGER BIOPHARMS drugs.
There are nine patent family members on EIGER BIOPHARMS drugs in six countries.
Drugs and US Patents for Eiger Biopharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eiger Biopharms | ZOKINVY | lonafarnib | CAPSULE;ORAL | 213969-002 | Nov 20, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Eiger Biopharms | ZOKINVY | lonafarnib | CAPSULE;ORAL | 213969-001 | Nov 20, 2020 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Eiger Biopharms | ZOKINVY | lonafarnib | CAPSULE;ORAL | 213969-002 | Nov 20, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Eiger Biopharms | ZOKINVY | lonafarnib | CAPSULE;ORAL | 213969-002 | Nov 20, 2020 | RX | Yes | Yes | 7,838,531 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Eiger Biopharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 1853265 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2006081444 | ⤷ Sign Up |
Japan | 2006507845 | ⤷ Sign Up |
European Patent Office | 1552020 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.